ArticleLancet (London, England)2020
Clinical course and mortality risk of severe COVID-19.
Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 374 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Impact of a Minimal Psychoeducational Intervention Versus Standard of Care on Anxiety Among Hospitalized COVID-19 Patients in Denmark: a Randomized Clinical Trial
Use of Remote Patient Monitoring (RPM) Platform for COVID-19 Patient
The Role of Cellular Therapy With SVF Cells (Stromal Vascular Fraction) of Adipose Tissue Origin in the Treatment of Pulmonary Fibrosis Post COVD-19
Who cites it
374 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- The accuracy of artificial intelligence in predicting COVID-19 patient mortality: a systematic review and meta-analysis.BMC medical informatics and decision making · 2023Pooled it
- Efficacy and Safety of Mesenchymal Stromal Cells Therapy for COVID-19 Infection: A Systematic Review and Meta-analysis.Current stem cell research & therapy · 2023Pooled it
- A systematic review of whether COVID-19 randomized controlled trials reported on demographic and clinical characteristics.Pharmacoepidemiology and drug safety · 2022Pooled it
- A Review of Mortality Risk Prediction Models in Smartphone Applications.Journal of medical systems · 2021Pooled it
- Maternal death related to COVID-19: A systematic review and meta-analysis focused on maternal co-morbidities and clinical characteristics.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2021Pooled it
- Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patients.The Laryngoscope · 2021Pooled it
- Efficacy and safety of add-on Viola odorata L. in the treatment of COVID-19: A randomized double-blind controlled trial.Journal of ethnopharmacology · 2023Trial
- A randomized controlled trial to evaluate outcomes with Aggrenox in patients with SARS-CoV-2 infection.PloS one · 2023Trial
- Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India.Lancet (London, England) · 2022Trial
- Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial.The Lancet. Infectious diseases · 2022Trial
- Possible Role of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Recovery of Post-COVID-19 Anosmia.Infection and drug resistance · 2022Trial
- Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021Trial
- Article
- Stable Solid Peracetic Acid Precursor for Effective Decontamination and Reuse of Personal Protective Equipment.ACS omega · 2026Article
- A data-driven analysis and forecasting of Leishmaniasis-COVID-19 co-infection model using ensemble Kalman filter.Scientific reports · 2026Article
- Cytotoxic CD4Signal transduction and targeted therapy · 2026Review
- Outcomes, Sequelae, and Ventilatory Strategies in Long COVID Patients with Severe ARDS: A Retrospective Cohort Study.Journal of clinical medicine · 2025Article
- The Interplay Between Immunological and Inflammatory Markers as Key Prognostic Indicators in Elderly Patients with COVID-19.Healthcare (Basel, Switzerland) · 2025Article
- Study on Age-specific Population at Risk of Developing Dementia, Anxiety and Depression Following Exposure to COVID-19.Annals of neurosciences · 2025Article
- Review
314 more citing papers are in PubMed but not listed here.
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.